Important role of endothelium-derived hyperpolarizing factor in shear stress-induced endothelium-dependent relaxations in the rat mesenteric artery

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 3, 1999, Pages 381-387

  Takamura, Yoshiaki ^a   Shimokawa, Hiroaki ^a   Zhao, Huiying ^a   Igarashi, Hirohito ^a   Egashira, Kensuke ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

EDHF; Endothelium; K channels; NO; Shear stress

Indexed keywords

APAMIN; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; PROSTAGLANDIN; TETRABUTYLAMMONIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM; MALE; MESENTERIC ARTERY; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SHEAR STRESS;

ANIMALS; BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; HEMORHEOLOGY; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; PROSTAGLANDINS; RATS; RATS, INBRED WKY; VASODILATION; VASODILATOR AGENTS;

EID: 0032837637     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199909000-00010     Document Type: Article

References (43)

1. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton: CRC Press, 1990:1-228.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide; physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
3. Fleming I, Bauersachs J, Busse R. Paracrine functions of the coronary vascular endothelium. Mol Cell Biochem 1996;157:137-45.
4. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999;31:23-37.
5. Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med 1995;27:331-40.
6. Shimokawa H, Vanhoutte PM. Endothelium and vascular injury in hypertension and atherosclerosis. In: Zanchetti A, Mancia G, eds. Handbook of hypertension. Amsterdam: Elsevier Science BV, 1997:1007-68.
7. Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol 1984;6:1161-9.
8. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37-44.
9. Bevan JA, Henrion D. Pharmacological implications of the flow-dependence of vascular smooth muscle tone. Annu Rev Pharmacol Toxicol 1994;34:173-90.
10. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250: H1145-9.
11. Koller A, Sun D, Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993;72:1276-84.
12. Kelm M, Schrader J. Control of vascular tone by nitric oxide. Circ Res 1990;66:1561-75.
13. Popp R, Fleming I, Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res 1998;82:696-703.
14. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996;28:703-11.
15. Ralevic V, Frantisek F, Hudlická O, Burnstock G. A new protocol for removal of the endothelium from the perfused rat hindlimb perfusion. Circ Res 1989;64:1190-6.
16. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 1984;12:463-79.
17. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997;100:2793-9.
18. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994;113:1548-53.
19. Kamiya A, Bukhari R, Togawa T. Adaptive regulation of wall shear stress optimizing vascular tree function. Bull Math Biol 1984;46:127-37.
20. Hansen PR, Haunso S. Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperemic response. Cardiovasc Res 1995;29:862-6.
21. Macho P, Domenech R, Penna M. Relative participation of adenosine and endothelium derived mediators in coronary reactive hyperemia in the dog. Biol Res 1995;28:165-71.
22. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2556-9.
23. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
24. Joyner MJ, Diez NM. Nitric oxide and vasodilation in human limbs. J Appl Physiol 1997;83:1785-96.
25. Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney Jr JF. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 1998;101:1408-14.
26. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Resp Cell Mol Biol 1993;8:1-6.
27. Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci 1997; 18:252-6.
28. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 1994; 481:407-14.
29. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415-23.
30. Weintraub NL, Joshi SN, Branch CA, Stephenson AH, Sprague RS, Lonigro AJ. Relaxation of porcine coronary artery to bradykinin: role of arachidonic acid. Hypertension 1994;23:976-81.
31. Corriu C, Féletou M, Canet E, Vanhoutte PM. Inhibitors of the cytochrome P450 monooxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br J Pharmacol 1996;117:607-10.
32. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br J Pharmacol 1997; 120:439-46.
33. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998;396:269-72.
34. Henrion D, Terzi F, Matrougui K, et al. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 1997;100:2909-14.
35. + channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries. J Physiol 1995;489:723-34.
36. McLenachan JM, Williams JK, David RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991;84: 1273-8.
37. Cox DA, Vita JA, Charles CB, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 1989;80:458-65.
38. Drexler H, Zeiher AM, Woiischläger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989;80:466-74.
39. Koller A, Huang A. Shear stress-induced dilation is attenuated in skeletal muscle arterioles of hypertensive rats. Hypertension 1995; 25:758-63.
40. Matrougui K, Macouf J, Levy BJ, Henrion D. Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 1997;30:942-7.
41. Kelm M, Preik M, Hafner DJ, Strauer BE. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with essential hypertension. Hypertension 1996;27:346-53.
42. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardiovasc Pharmacol 1997;30:481-8.
43. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Long-term treatment with eicosapentanenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 1999; 33:633-40.